» Articles » PMID: 33441982

Serotonin Receptor 4 in the Hippocampus Modulates Mood and Anxiety

Overview
Journal Mol Psychiatry
Date 2021 Jan 14
PMID 33441982
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Serotonin receptor 4 (5-HTR) plays an important role in regulating mood, anxiety, and cognition, and drugs that activate this receptor have fast-acting antidepressant (AD)-like effects in preclinical models. However, 5-HTR is widely expressed throughout the central nervous system (CNS) and periphery, making it difficult to pinpoint the cell types and circuits underlying its effects. Therefore, we generated a Cre-dependent 5-HTR knockout mouse line to dissect the function of 5-HTR in specific brain regions and cell types. We show that the loss of functional 5-HTR specifically from excitatory neurons of hippocampus led to robust AD-like behavioral responses and an elevation in baseline anxiety. 5-HTR was necessary to maintain the proper excitability of dentate gyrus (DG) granule cells and cell type-specific molecular profiling revealed a dysregulation of genes necessary for normal neural function and plasticity in cells lacking 5-HTR. These adaptations were accompanied by an increase in the number of immature neurons in ventral, but not dorsal, dentate gyrus, indicating a broad impact of 5-HTR loss on the local cellular environment. This study is the first to use conditional genetic targeting to demonstrate a direct role for hippocampal 5-HTR signaling in modulating mood and anxiety. Our findings also underscore the need for cell type-based approaches to elucidate the complex action of neuromodulatory systems on distinct neural circuits.

Citing Articles

Transcriptomic mapping of the 5-HT receptor landscape.

De Filippo R, Schmitz D Patterns (N Y). 2024; 5(10):101048.

PMID: 39569210 PMC: 11574285. DOI: 10.1016/j.patter.2024.101048.


Studies on the mechanisms of action of MR33317.

Neumann J, Hesse C, Yahiaoui S, Dallemagne P, Rochais C, Hofmann B Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8893-8902.

PMID: 38856912 PMC: 11522085. DOI: 10.1007/s00210-024-03226-0.


Sialic Acid-Functionalized Gold Nanoparticles for Sensitive and Selective Colorimetric Determination of Serotonin.

Avci B, Akpinar Y, Ertas G, Volkan M ACS Omega. 2024; 9(22):23832-23842.

PMID: 38854544 PMC: 11154895. DOI: 10.1021/acsomega.4c01859.


The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders.

Sgambato V Int J Mol Sci. 2024; 25(10).

PMID: 38791281 PMC: 11121119. DOI: 10.3390/ijms25105245.


Interaction of serotonin/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction.

Kolling L, Khan K, Wang R, Pierson S, Hartman B, Balasubramanian N Psychiatry Res. 2024; 337:115951.

PMID: 38735240 PMC: 11267813. DOI: 10.1016/j.psychres.2024.115951.


References
1.
Price J, Drevets W . Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci. 2011; 16(1):61-71. DOI: 10.1016/j.tics.2011.12.011. View

2.
Ressler K, Mayberg H . Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007; 10(9):1116-24. PMC: 2444035. DOI: 10.1038/nn1944. View

3.
Krishnan V, Nestler E . The molecular neurobiology of depression. Nature. 2008; 455(7215):894-902. PMC: 2721780. DOI: 10.1038/nature07455. View

4.
Ferguson J . SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry. 2004; 3(1):22-27. PMC: 181155. DOI: 10.4088/pcc.v03n0105. View

5.
Schmidt E, Warner-Schmidt J, Otopalik B, Pickett S, Greengard P, Heintz N . Identification of the cortical neurons that mediate antidepressant responses. Cell. 2012; 149(5):1152-63. PMC: 3397430. DOI: 10.1016/j.cell.2012.03.038. View